Post-COVID Strategy: Invest, Don’t Save, Even If There's A Second Lockdown
What should consumer health companies be doing as Europe comes out of lockdown? Invest in key brands, says Sempora Consulting's managing partner Tobias Brodtkorb, and consider seizing the opportunity presented by the long-term trend for natural OTCs, which has been accelerated by the coronavirus pandemic.
You may also be interested in...
HBW Insight extracts five key lessons from 2020, the year the coronavirus pandemic swept its way across Europe.
HBW Insight speaks to industry expert Paul Wardle - who worked on Pfizer's Viagra switch - about how data analytics can help firms extract the “beacons of insight” to create the consumer health brands of tomorrow.
Germany's OTC market blues continue as the coronavirus lockdown bites into May.